

Drug developer Syntopix said it narrowed pre-tax losses in 2009 and is planning a share sale to fund the development of its products. Pre-tax loss na...


Footsie hit a new intra-day high for the year in mid-afternoon, but buyer interest tailed off near the close as US markets retreated on a mild resurge...


Drug developer Syntopix shares rallied as it reported positive phase 2 results for its lead dermatological compound SYN0126, for the treatment of acne...